Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that affects primarily the motor nervous system. It results in involuntary muscle twitches (fasciculations), muscle wasting (atrophy), and muscle weakness (paresis) in the arms and legs as well as in the respiratory muscles once motor nerve cells in the spinal cord and their extensions to the muscles are affected. The muscles that control speech, chewing, and swallowing become weak if the motor nerve cells in the brainstem are affected. The cause of ALS is 90% unknown. However, familial ALS accounts for 10% of all cases.

Regentime Stem Cell Therapy comes here to slow the disease progression by exerting a neuro-protective effect, reducing apoptosis, increasing the secretion of neurotrophic factors by glial cells (the cells in the brain which support neurons), reducing oxidative stress, and modulating the inflammatory process in the brain (stimulation of M2 cells that liberates anti-inflammatory bio compounds).

Autologous bone marrow derived stem cells are collected from the patient’s iliac crest, differentiated in the laboratory, and injected back into the patient’s own body in 2 routes: Intravenous and Intrathecal (lumbar puncture). This procedure takes 5 days, with prices ranging from 25,000 USD to 36,700 USD